Log in
NASDAQ:PETQ

PetIQ Stock Forecast, Price & News

$31.31
-0.32 (-1.01 %)
(As of 09/17/2020 12:00 AM ET)
Add
Compare
Today's Range
$30.74
Now: $31.31▼
$31.63
50-Day Range
$29.33
MA: $32.76▼
$37.49
52-Week Range
$15.83
Now: $31.31▼
$38.99
Volume124,784 shs
Average Volume394,095 shs
Market Capitalization$894.59 million
P/E RatioN/A
Dividend YieldN/A
Beta1.55
PetIQ, Inc. operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers Rx pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and OTC medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company offers its products primarily under the PetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 39 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It sells its products through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Read More
PetIQ logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.58 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PETQ
Previous Symbol
CUSIPN/A
CIK1668673
Webwww.petiq.com
Phone208-939-8900

Debt

Debt-to-Equity Ratio1.04
Current Ratio3.06
Quick Ratio2.17

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio45.38
P/E Growth1.81

Sales & Book Value

Annual Sales$709.43 million
Price / Sales1.26
Cash Flow$1.44 per share
Price / Cash Flow21.76
Book Value$11.60 per share
Price / Book2.70

Profitability

EPS (Most Recent Fiscal Year)$1.07
Net Income$-11,450,000.00
Net Margins-2.63%
Return on Equity8.52%
Return on Assets3.85%

Miscellaneous

Employees1,866
Outstanding Shares28,572,000
Market Cap$894.59 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$31.31
-0.32 (-1.01 %)
(As of 09/17/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PETQ News and Ratings via Email

Sign-up to receive the latest news and ratings for PETQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PetIQ (NASDAQ:PETQ) Frequently Asked Questions

How has PetIQ's stock been impacted by Coronavirus (COVID-19)?

PetIQ's stock was trading at $22.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PETQ shares have increased by 38.6% and is now trading at $31.31.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of PetIQ?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PetIQ.

When is PetIQ's next earnings date?

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for PetIQ.

How were PetIQ's earnings last quarter?

PetIQ Inc (NASDAQ:PETQ) issued its quarterly earnings data on Thursday, August, 6th. The company reported $0.70 earnings per share for the quarter, topping analysts' consensus estimates of $0.44 by $0.26. The firm earned $266.98 million during the quarter, compared to the consensus estimate of $251.20 million. PetIQ had a negative net margin of 2.63% and a positive return on equity of 8.52%.
View PetIQ's earnings history.

What guidance has PetIQ issued on next quarter's earnings?

PetIQ issued an update on its third quarter 2020 After-Hours earnings guidance on Thursday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $160-170 million, compared to the consensus revenue estimate of $205.77 million.

What price target have analysts set for PETQ?

4 analysts have issued 12-month price targets for PetIQ's shares. Their forecasts range from $43.00 to $175.00. On average, they anticipate PetIQ's stock price to reach $78.25 in the next twelve months. This suggests a possible upside of 149.9% from the stock's current price.
View analysts' price targets for PetIQ.

Are investors shorting PetIQ?

PetIQ saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 5,460,000 shares, an increase of 17.9% from the August 15th total of 4,630,000 shares. Based on an average daily trading volume, of 433,300 shares, the short-interest ratio is presently 12.6 days.
View PetIQ's Short Interest.

Who are some of PetIQ's key competitors?

Some companies that are related to PetIQ include Nu Skin Enterprises (NUS), (BTCA) (BTCA), Trxade Group (TRXD), MultiCell Technologies (MEDS), biOasis Technologies (BIOAF) and China Medicine (CHME).
View all competitors.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), CVS Health (CVS), Intel (INTC), QUALCOMM (QCOM), Oracle (ORCL) and Skyworks Solutions (SWKS).

Who are PetIQ's key executives?

PetIQ's management team includes the following people:
  • Mr. McCord Christensen, Chairman & CEO (Age 47)
  • Ms. Susan Sholtis, Pres (Age 53)
  • Mr. John Newland, Chief Financial Officer (Age 55)
  • Mr. Robert Michael Herrman, Gen. Counsel & Sec.
  • Mr. Adam Fellers, Sr. VP of Sales

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Who are PetIQ's major shareholders?

PetIQ's stock is owned by many different institutional and retail investors. Top institutional investors include Wasatch Advisors Inc. (5.72%), Vanguard Group Inc. (3.67%), Shannon River Fund Management LLC (3.55%), Ensign Peak Advisors Inc (2.90%), Riverbridge Partners LLC (2.36%) and Peregrine Capital Management LLC (2.16%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Robert Michael Herrman, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ.

Which major investors are selling PetIQ stock?

PETQ stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Goldman Sachs Group Inc., Gabelli Funds LLC, Peregrine Capital Management LLC, Gamco Investors INC. ET AL, Aperture Investors LLC, Intrinsic Edge Capital Management LLC, and WINTON GROUP Ltd.
View insider buying and selling activity for PetIQ.

Which major investors are buying PetIQ stock?

PETQ stock was acquired by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Driehaus Capital Management LLC, Bank of America Corp DE, Cadence Capital Management LLC, Sei Investments Co., Wasatch Advisors Inc., Marshall Wace North America L.P., and TRH Financial LLC. Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ.

How do I buy shares of PetIQ?

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $31.31.

How big of a company is PetIQ?

PetIQ has a market capitalization of $894.59 million and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. PetIQ employs 1,866 workers across the globe.

What is PetIQ's official website?

The official website for PetIQ is www.petiq.com.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.